<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516488</url>
  </required_header>
  <id_info>
    <org_study_id>2014C0205</org_study_id>
    <nct_id>NCT02516488</nct_id>
  </id_info>
  <brief_title>Comparison of CLE in Vivo Diagnosis and ex Vivo Examination Against Surgical Histopathology of CPL</brief_title>
  <acronym>INDEX</acronym>
  <official_title>Comparison of Confocal Laser Endomicroscopic IN Vivo Diagnosis and EX Vivo Examination (INDEX Study) Against Surgical Histopathology of Cystic Pancreatic Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Somashekar Krishna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of confocal laser endomicroscopic in vivo diagnosis and ex vivo examination&#xD;
      against surgical histopathology of cystic pancreatic lesions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to assess the ability of nCLE (AQ-Flex) to accurately&#xD;
      diagnose the type of CPL by comparing in vivo and ex vivo CLE patterns to final&#xD;
      histopathology of surgically resected CPLs. The primary endpoints are whether or not the CLE&#xD;
      diagnosis correlates with final diagnosis (yes vs. no).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">March 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of cystic pancreatic lesion (CPL) using nCLE (confocal laser endomicroscopy)</measure>
    <time_frame>12 months</time_frame>
    <description>Comparing the ability of nCLE to accurately diagnose the type of CPL by comparing in vivo and ex vivo CLE patterns to final histopathology of surgically resected CPLs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of high-grade dysplasia and/or adenocarcinoma by CLE imaging</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CLE imaging interpretation variation</measure>
    <time_frame>12 months</time_frame>
    <description>Calculate inter-observer variation in CLE image interpretation</description>
  </secondary_outcome>
  <enrollment type="Actual">145</enrollment>
  <condition>Cystic Pancreatic Disorders</condition>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Fluid from cyst in pancreas&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Cystic Pancreatic Lesions&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For in vivo nCLE (needle-based confocal laser endomicroscopy) (Part 1):&#xD;
&#xD;
          -  Patient age 18 years and older&#xD;
&#xD;
          -  All patients referred for EUS-FNA (endoscopic ultrasound - fine needle aspiration) of&#xD;
             accessible CPL (cystic pancreatic lesion)&#xD;
&#xD;
          -  The minimum size of the cyst should be â‰¥ 1.5 cm as determined by prior cross-sectional&#xD;
             imaging studies.&#xD;
&#xD;
        For ex vivo pCLE (probe-based confocal laser endomicroscopy) (Part 2):&#xD;
&#xD;
          -  All patients must satisfy inclusive criteria for in vivo nCLE.&#xD;
&#xD;
          -  All patients should have completed EUS-guided nCLE.&#xD;
&#xD;
          -  All patients should have a CPL lesion referred for surgical removal based on&#xD;
             recommended international consensus guidelines1 and inter-departmental consensus&#xD;
             pancreatic tumor board meeting (departments of surgical oncology, radiology, pathology&#xD;
             and gastroenterology).&#xD;
&#xD;
          -  Patient participated and completed in vivo nCLE (Part 1)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to obtain informed consent&#xD;
&#xD;
          -  Unable to tolerate the procedure&#xD;
&#xD;
          -  Women with known pregnancy at time of procedure&#xD;
&#xD;
          -  Patient age less than 18 years&#xD;
&#xD;
          -  Bleeding diathesis&#xD;
&#xD;
          -  Lesion not accessible by EUS guided FNA&#xD;
&#xD;
          -  Allergy to fluorescein.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Somashekar Krishna, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State Wexner Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OSU Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2015</study_first_posted>
  <last_update_submitted>October 15, 2019</last_update_submitted>
  <last_update_submitted_qc>October 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Somashekar Krishna</investigator_full_name>
    <investigator_title>Assistant Professor-Clinical</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

